2009
DOI: 10.1289/ehp.0900753
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear Hormone Receptor Activity of Polybrominated Diphenyl Ethers and Their Hydroxylated and Methoxylated Metabolites in Transactivation Assays Using Chinese Hamster Ovary Cells

Abstract: Background: An increasing number of studies are reporting the existence of polybrominated diphenyl ethers (PBDEs) and their hydroxylated (HO) and methoxylated (MeO) metabolites in the environment and in tissues from wildlife and humans. oBjective: Our aim was to characterize and compare the agonistic and antagonistic activities of principle PBDE congeners and their HO and MeO metabolites against human nuclear hormone receptors. Methods: We tested the hormone receptor activities of estrogen receptor α (ERα), ER… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
149
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 216 publications
(161 citation statements)
references
References 55 publications
11
149
1
Order By: Relevance
“…12,31,34 Using the reporter gene assay in Chinese hamster ovary cells, four OH-PBDEs (4 0 -OH-BDE-17, 4-OH-BDE-42, 4 0 -OH-BDE-49, 4-OH-BDE-90) did not show any agonistic activity, but 4-OH-BDE-90 exhibited a weak antagonistic activity for both TR isoforms. 35 In contrast, all the tested 18 OH-PBDEs showed 33 It is obvious that the results summarized above are fairly inconsistent, and both agonistic and antagonistic activities have been reported even for the same PBDE or OH-PBDE. This is probably because different cell lines were used in these studies.…”
Section: Thyroid Hormone Receptor Pathwaymentioning
confidence: 97%
“…12,31,34 Using the reporter gene assay in Chinese hamster ovary cells, four OH-PBDEs (4 0 -OH-BDE-17, 4-OH-BDE-42, 4 0 -OH-BDE-49, 4-OH-BDE-90) did not show any agonistic activity, but 4-OH-BDE-90 exhibited a weak antagonistic activity for both TR isoforms. 35 In contrast, all the tested 18 OH-PBDEs showed 33 It is obvious that the results summarized above are fairly inconsistent, and both agonistic and antagonistic activities have been reported even for the same PBDE or OH-PBDE. This is probably because different cell lines were used in these studies.…”
Section: Thyroid Hormone Receptor Pathwaymentioning
confidence: 97%
“…Kojima et al [58] both positions adjacent to the hydroxyl group. This structural factor seems to be a good predictor of a competitive inhibition mechanism, which could explain, at least partially, the antagonistic activity of OH-PBDEs at the TR.…”
Section: Trs?mentioning
confidence: 99%
“…167,187,188 Cell based assays have shown that some OH-BDEs, including 3-OH-BDE-47, can inhibit T3 binding to TRs by antagonizing the receptor, whereas several other parent PBDEs and OH-BDEs have shown no TR affinity. 189,190 Another study showed TR antagonistic activity for BDE-209, -153, -154, -100, and PentaBDE. 191 Limited evidence has shown some OH-BDEs to behave as weak TR agonists.…”
Section: Binding To Thyroid Receptorsmentioning
confidence: 99%